Related Experiment Video
Updated: Dec 25, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Association Between Parkinson's Disease and Melanoma: Putting the Pieces Together
Qing Ye1, Ya Wen1,2, Nasser Al-Kuwari1
1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Abstract:
Patients with Parkinson's disease (PD) generally have reduced risk of developing many types of cancers, except melanoma-a malignant tumor of melanin-producing cells in the skin. For decades, a large number of epidemiological studies have reported that the occurrence of melanoma is higher than expected among subjects with PD, and the occurrence of PD is reciprocally higher than expected among patients with melanoma. More recent epidemiological studies further indicated a bidirectional association, not only in the patients themselves but also in their relatives. This association between PD and melanoma offers a unique opportunity to understand PD. Here, we summarize epidemiological, clinical, and biological evidence in regard to shared risk factors and possible underlying mechanisms for these two seemingly distinct conditions.
Insights
Parkinson's disease (PD) patients show a higher risk of melanoma, a skin cancer. This bidirectional link between PD and melanoma suggests shared underlying factors warranting further investigation.
Area of Science:
- Neuroscience
- Oncology
- Epidemiology
Background:
- Parkinson's disease (PD) is associated with a reduced risk of most cancers.
- However, epidemiological studies consistently report an elevated incidence of melanoma among PD patients.
- Conversely, Parkinson's disease (PD) occurrence is also higher than expected in melanoma patients.
Purpose of the Study:
- To review epidemiological, clinical, and biological evidence on the association between Parkinson's disease (PD) and melanoma.
- To explore shared risk factors and potential mechanisms underlying this bidirectional relationship.
Main Methods:
- Systematic review of epidemiological studies.
- Analysis of clinical data.
- Examination of biological evidence for shared pathways.
Main Results:
- Consistent epidemiological evidence supports a bidirectional association between Parkinson's disease (PD) and melanoma.
- This association extends to the relatives of affected individuals.
- Shared risk factors and biological mechanisms are increasingly recognized.
Conclusions:
- The unique association between Parkinson's disease (PD) and melanoma provides a valuable model for understanding PD pathogenesis.
- Further research into shared etiological factors is crucial for both conditions.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Neural Regulation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...

